Zhejiang Conba Pharmaceutical Co., Ltd. Class ASSE: 600572

Announcement on Implementation of Independent Exercise in the 2nd Exercise Period of Stock Options Initially Granted in 2022 Stock Option Incentive Plan

· Issued by Zhejiang Conba Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Implementation of Independent Exercise in the 2nd Exercise Period of Stock Options Initially Granted in 2022 Stock Option Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis